TapRoot Interventions & Solutions, Inc (TapRoot) is partnering with psychiatric and behavioral health provider group Peace of Mind Consultants (POMC) in Arizona to provide Ella® to their patients and business partners. Ella is a digital careplan platform that provides interventions to prevent, decrease, and de-escalate dementia-related and mental illness-related behavioral symptoms known to occur in Long Term Care communities. POMC will use Ella to garner key insights from caregiver feedback in order to tailor patient-specific treatment plans and determine appropriate use of medications. The value of the partnership is a provider service model coupled with a caregiver platform to assess, evaluate, and provide outcome measures to improve overall resident care.Continue reading
Category Archives: AZBio News
C-Path and Ultragenyx Announce Data Sharing Agreement to Support Rare Disease Treatment and Novel Therapies
TUCSON, Ariz., Dec. 1, 2022 — Critical Path Institute (C-Path) and Ultragenyx Pharmaceutical, Inc., (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced a data sharing agreement to incorporate rare disease patient data into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading
NEW AZBio Member Benefit – Tax Credit Services from ADP
ADP provides an experienced and practical approach for guiding life science clients through the R&D tax credit process. Their group of specialized professionals provide the peace of mind that comes with having a highly detailed study outlining qualified research activities and expenses.Continue reading
Five Arizona Researchers Make the List of Top1,000 Female Scientists in the World
For the first time, Research.com has published a list of the top 1,000 female scientists in the world.
Congratulations to Barbara Ainsworth, Carol Barnes, Carolyn Compton, Nancy Eisenberg, and Alexandra Navrotsky for this well earned recognition.Continue reading
Arizona Tech Investors Announces New CEO
Bob DeLean to Direct Arizona’s Leading Angel Investing Group’s Next StageContinue reading
AZAdvances is working to support health innovation in Arizona
How You Can Help Advance Health InnovationContinue reading
U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
- This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy and generates elevated and sustained factor IX levels for years after a one-time infusion
- With the approval of HEMGENIX, CSL now offers an even more comprehensive portfolio of treatments for people living with hemophilia B, ushering in a new era of treatment options
Student Opportunity – 2023 KEYS Internships
The 2023 KEYS Research Internship applications opened November 21, 2022.Continue reading
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer
PHOENIX, Arizona and OSLO, Norway — November 21, 2022 — Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a Norwegian clinical stage precision health company, today report that the ultrasound based Acoustic Cluster Therapy (ACT®) significantly enhanced the antitumor efficacy of standard care therapies in a preclinical model for pancreatic cancer.Continue reading
Five Leaders Elected to the AZBio Board of Directors
Tony Caldwell of Snell & Wilmer, Brandy Flores of Pfizer, Renée Galá of Jazz Pharmaceuticals, Shannon Groppenbacher of Johnson & Johnson, and Nathan Trembath of Bristol Myers Squibb, join the Arizona Bioindustry Association leadership team.Continue reading